Letter: Alopecia areata during ustekinumab administration: Coexistence or an adverse reaction?

Dermatology Online Journal

Volumn 18, Issue 7, 2012, Pages

  Verros, Constantinos ^a   Rallis, Efstathios ^b   Crowe, Mark ^a  

^a Department of Dermatology ^*

^b Veterans Administration Hospital NIMTS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; BETAMETHASONE VALERATE; CLOBETASOL PROPIONATE; ETANERCEPT; USTEKINUMAB; ANTIINFLAMMATORY AGENT; BETAMETHASONE; CLOBETASOL; MONOCLONAL ANTIBODY;

ADULT; ALOPECIA AREATA; CASE REPORT; DISEASE DURATION; DRUG EFFICACY; DRUG SAFETY; HISTOLOGY; HUMAN; HUMAN TISSUE; LETTER; MALE; PSORIASIS; PUNCH BIOPSY; TREATMENT RESPONSE; MIDDLE AGED; TREATMENT OUTCOME;

ALOPECIA AREATA; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; BETAMETHASONE; CLOBETASOL; HUMANS; MALE; MIDDLE AGED; PSORIASIS; TREATMENT OUTCOME;

EID: 84864009015     PISSN: 10872108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Paus R, Olsen E, Messenger A. Hair growth disorders. In: Wolff K, Goldsmith L, Katz S, Gilchrest B, Paller A, Leffell D, (eds) Fitzpatrick's Dermatology in General Medicine, 7th edn. McGraw-Hill, 2007;753-77.
2. Barahmani N, Lopez A, Babu D, Hernandez M, Donely SE, Duvic M. Serum T helper 1 cytokine levels are greater in patients with alopecia areata regardless of severity or atopy. Clin Exp Dermatol 2010;35:409-16.
3. Słowińska M, Kardynal A, Warszawik O, Czuwara J, Rudnicka L. Alopecia areata developing paralell to improvement of psoriasis during ustekinumab therapy. J Dermatol Case Rep 2010;4:15-7.
4. Tosti A, Pazzaglia M, Starace M, Bellavista S, Vincenzi C, Tonelli G. Alopecia areata during treatment with biologic agents. Arch Dermatol 2006;142:1653-4.
5. Kos L, Conlon J. An update on alopecia areata. Curr Opin Pediatr 2009;21:475-80.